To access this element change to forms mode OFF
Grant Award View - GA276585
Targeting phenotypic plasticity to treat chemotherapy-resistant cancer
GA ID:
GA276585
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2026
Value (AUD):
$929,996.50
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Targeting phenotypic plasticity to treat chemotherapy-resistant cancer
Purpose:
Some cancer cells are very aggressive. Those cells are the reason why cancers become resistant to chemotherapy. If we can eradicate the aggressive cells we can improve survival outcomes for patients. We have identified a new target, SULF1, that is required for cancer cells to be aggressive and evade chemotherapy. We now aim to show that by targeting SULF1 we can stop cancers from spreading and make them susceptible to chemotherapy.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2019437
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Kensington
Town/City:
Kensington
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW
Postcode:
Multiple
Country:
AUSTRALIA